Fresenius SE & Co. KGaA (FSNUF)
USD 37.73
(-5.68%)
USD 37.73
(-5.68%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 13.26 Billion EUR | -48.15% |
| 2022 | 25.58 Billion EUR | 4.25% |
| 2021 | 24.54 Billion EUR | 1.95% |
| 2020 | 24.07 Billion EUR | -5.97% |
| 2019 | 25.6 Billion EUR | 55.88% |
| 2018 | 16.42 Billion EUR | -5.64% |
| 2017 | 17.4 Billion EUR | 30.65% |
| 2016 | 13.32 Billion EUR | -2.93% |
| 2015 | 13.72 Billion EUR | -4.48% |
| 2014 | 14.36 Billion EUR | 20.02% |
| 2013 | 11.97 Billion EUR | 17.27% |
| 2012 | 10.2 Billion EUR | 89.51% |
| 2011 | 5.38 Billion EUR | -37.13% |
| 2010 | 8.56 Billion EUR | 59.93% |
| 2009 | 5.35 Billion EUR | 298.07% |
| 2008 | 1.34 Billion EUR | 472.85% |
| 2007 | -361 Million EUR | -38.31% |
| 2006 | -261 Million EUR | -3.57% |
| 2005 | -252 Million EUR | -80.0% |
| 2004 | -140 Million EUR | -2100.0% |
| 2003 | 7 Million EUR | -98.23% |
| 2002 | 395 Million EUR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 13.48 Billion EUR | 1.64% |
| 2024 Q2 | 12.42 Billion EUR | -7.84% |
| 2023 FY | 13.26 Billion EUR | -48.15% |
| 2023 Q3 | 14.02 Billion EUR | -45.47% |
| 2023 Q4 | 13.26 Billion EUR | -5.37% |
| 2023 Q2 | 25.71 Billion EUR | 1.05% |
| 2023 Q1 | 25.44 Billion EUR | -0.56% |
| 2022 Q2 | 26.23 Billion EUR | 4.4% |
| 2022 Q4 | 25.58 Billion EUR | -3.36% |
| 2022 FY | 25.58 Billion EUR | 4.25% |
| 2022 Q1 | 25.13 Billion EUR | 2.4% |
| 2022 Q3 | 26.47 Billion EUR | 0.91% |
| 2021 Q4 | 24.54 Billion EUR | -0.94% |
| 2021 Q2 | 25.03 Billion EUR | 1.66% |
| 2021 Q3 | 24.77 Billion EUR | -1.04% |
| 2021 FY | 24.54 Billion EUR | 1.95% |
| 2021 Q1 | 24.63 Billion EUR | 2.31% |
| 2020 Q3 | 24.33 Billion EUR | -0.31% |
| 2020 Q1 | 26.52 Billion EUR | 3.61% |
| 2020 FY | 24.07 Billion EUR | -5.97% |
| 2020 Q2 | 24.41 Billion EUR | -7.97% |
| 2020 Q4 | 24.07 Billion EUR | -1.08% |
| 2019 Q1 | 24.83 Billion EUR | 51.2% |
| 2019 FY | 25.6 Billion EUR | 55.88% |
| 2019 Q4 | 25.6 Billion EUR | 0.75% |
| 2019 Q3 | 25.41 Billion EUR | -0.01% |
| 2019 Q2 | 25.41 Billion EUR | 2.34% |
| 2018 Q1 | 17.71 Billion EUR | 1.78% |
| 2018 FY | 16.42 Billion EUR | -5.64% |
| 2018 Q4 | 16.42 Billion EUR | -0.48% |
| 2018 Q3 | 16.5 Billion EUR | -1.3% |
| 2018 Q2 | 16.72 Billion EUR | -5.61% |
| 2017 Q1 | 18.73 Billion EUR | 40.58% |
| 2017 FY | 17.4 Billion EUR | 30.65% |
| 2017 Q2 | 18.53 Billion EUR | -1.02% |
| 2017 Q4 | 17.4 Billion EUR | -3.43% |
| 2017 Q3 | 18.02 Billion EUR | -2.78% |
| 2016 Q2 | 13.86 Billion EUR | 1.43% |
| 2016 Q1 | 13.66 Billion EUR | -0.42% |
| 2016 Q4 | 13.32 Billion EUR | -0.16% |
| 2016 Q3 | 13.34 Billion EUR | -3.73% |
| 2016 FY | 13.32 Billion EUR | -2.93% |
| 2015 Q1 | 14.94 Billion EUR | 4.03% |
| 2015 Q4 | 13.72 Billion EUR | -3.77% |
| 2015 Q3 | 14.26 Billion EUR | -3.27% |
| 2015 Q2 | 14.74 Billion EUR | -1.36% |
| 2015 FY | 13.72 Billion EUR | -4.48% |
| 2014 Q1 | 12.94 Billion EUR | 8.09% |
| 2014 FY | 14.36 Billion EUR | 20.02% |
| 2014 Q4 | 14.36 Billion EUR | 3.8% |
| 2014 Q3 | 13.84 Billion EUR | 2.87% |
| 2014 Q2 | 13.45 Billion EUR | 4.0% |
| 2013 FY | 11.97 Billion EUR | 17.27% |
| 2013 Q1 | 10.17 Billion EUR | -0.34% |
| 2013 Q2 | 10.36 Billion EUR | 1.85% |
| 2013 Q3 | 10.2 Billion EUR | -1.51% |
| 2013 Q4 | 11.97 Billion EUR | 17.3% |
| 2012 FY | 10.2 Billion EUR | 89.51% |
| 2012 Q3 | 10.35 Billion EUR | -6.03% |
| 2012 Q2 | 11.02 Billion EUR | 130.16% |
| 2012 Q1 | 4.78 Billion EUR | -11.12% |
| 2012 Q4 | 10.2 Billion EUR | -1.41% |
| 2011 Q1 | 8.02 Billion EUR | -6.35% |
| 2011 Q2 | 8.95 Billion EUR | 11.63% |
| 2011 Q3 | 8.52 Billion EUR | -4.81% |
| 2011 Q4 | 5.38 Billion EUR | -36.82% |
| 2011 FY | 5.38 Billion EUR | -37.13% |
| 2010 Q3 | 7.49 Billion EUR | -15.36% |
| 2010 Q4 | 8.56 Billion EUR | 14.39% |
| 2010 FY | 8.56 Billion EUR | 59.93% |
| 2010 Q2 | 8.85 Billion EUR | 8.98% |
| 2010 Q1 | 8.12 Billion EUR | 51.57% |
| 2009 FY | 5.35 Billion EUR | 298.07% |
| 2009 Q4 | 5.35 Billion EUR | 0.0% |
| 2008 FY | 1.34 Billion EUR | 472.85% |
| 2007 FY | -361 Million EUR | -38.31% |
| 2006 FY | -261 Million EUR | -3.57% |
| 2005 FY | -252 Million EUR | -80.0% |
| 2004 FY | -140 Million EUR | -2100.0% |
| 2003 FY | 7 Million EUR | -98.23% |
| 2002 FY | 395 Million EUR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| The Amacore Group, Inc. | -469.62 Thousand USD | 2825314.851% |
| Arem Pacific Corporation | 181.02 Thousand USD | -7329355.373% |
| Assisted 4 Living, Inc. | -199.71 Thousand USD | 6643666.736% |
| BioCorRx Inc. | 5.56 Million USD | -238125.839% |
| Bionik Laboratories Corp. | 1.98 Million USD | -668338.017% |
| Banyan Corp. | 3.6 Million USD | -367783.861% |
| Clearday, Inc. | 44.86 Million USD | -29471.195% |
| Dental Patient Care America, Inc. | -1.99 Million USD | 664498.258% |
| Quantum Medical Transport, Inc. | 1065.27 USD | -1245505734.202% |
| Empower Clinics Inc. | 2.29 Million USD | -577058.897% |
| First Choice Healthcare Solutions, Inc. | 23.22 Million USD | -57016.295% |
| Selectis Health, Inc. | 35.76 Million USD | -37000.9% |
| Ethema Health Corporation | 14.51 Million USD | -91311.854% |
| HealthLynked Corp. | 1.72 Million USD | -768382.265% |
| HQDA Elderly Life Network Corp. | - USD | -Infinity% |
| Healthcare Solutions Management Group, Inc. | 13.79 Million USD | -96091.232% |
| JRSIS Health Care Corporation | 911.83 Thousand USD | -1454991.009% |
| Comjoyful International Company | -28.32 Thousand USD | 46835498.355% |
| Medical Facilities Corporation | 92.22 Million USD | -14287.063% |
| MedSmart Group Inc. | 659.56 Thousand USD | -2011541.076% |
| North America Frac Sand, Inc. | 265.41 Thousand USD | -4998863.887% |
| Nova Leap Health Corp. | -686.52 Thousand USD | 1932728.917% |
| Nexteligent Holdings, Inc. | 1.83 Million USD | -721671.463% |
| PAO Group, Inc. | 639.37 Thousand USD | -2075051.515% |
| Primemd Inc. | 4.54 Million USD | -291914.564% |
| Raffles Medical Group Ltd | -194.49 Million USD | 6921.856% |
| Ryman Healthcare Limited | 1.51 Billion USD | -778.361% |
| Stem Cell Authority, Ltd. | 15.00 USD | -88453333233.333% |
| SETO Holdings, Inc. | - USD | -Infinity% |
| Optima Medical Innovations Corp. | 1.24 Million USD | -1067214.499% |
| Mycotopia Therapies, Inc. | 811.51 Thousand USD | -1634862.669% |
| U.S. NeuroSurgical Holdings, Inc. | -381 Thousand USD | 3482514.698% |
| Veltex Corporation | 2.17 Million USD | -608685.544% |
| World Financial Holding Group | 98.11 Thousand USD | -13523082.453% |
| Xcelerate Inc. | 1.18 Million USD | -1121678.206% |